StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.84−0.03 (-1.05%)

Close on Nov 17, 2026Market cap $560.13MP/E –Yield –

Wave Life Sciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Wave Life Sciences's price to book ratio was 1.5× on Nov 11, 2026, against 10.7× a year earlier. Over the last 5 years it ranged from 1.5× to 31.8×, with a median of 6.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.5×−20.4
2025Dec 31, 202521.9×+8.9
2024Dec 31, 202413.0×−0.5
2022Oct 31, 202213.4×+8.0
2021Dec 31, 20215.5×+1.9
2020Dec 31, 20203.5×+1.2
2019Dec 31, 20192.4×−9.2
2018Dec 31, 201811.6×+5.7
2017Dec 29, 20175.9×+1.8
2016Dec 30, 20164.1×–

More Wave Life Sciences figures

See a number that looks wrong?